TCL Archive Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS September 27, 1991
TCL Archive GA Draft Report Lukewarm On Cancer Survival Improvement; NCI Says It Is “Opinion, Not Fact” April 3, 1987
TCL Archive In Brief: Waxman Now Key House Health Figure; Kennedy Subcommittee Beefed Up with Top Democrats February 9, 1979
TCL Archive Budget Cuts Delay New Cooperative Drug Discovery Groups For Lung, Colon Cancer At Least One Year February 21, 1986
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
